(Q45367475)

13 December 2017

title

Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: outcome at 2 Years (English)

1 reference

13 December 2017

1 reference

1 reference

1 reference

1

1 reference

13 December 2017

Ching-Lung Lai

2

0 references

Ivan Fan Ngai Hung

8

object named as

Ivan Fan-Ngai Hung

1 reference

13 December 2017

John Yuen

3

1 reference

13 December 2017

Charles Cheng

4

1 reference

13 December 2017

Ringo Wu

5

1 reference

13 December 2017

Danny Ka-Ho Wong

6

1 reference

13 December 2017

Wai-Kay Seto

7

1 reference

13 December 2017

Man-Fung Yuen

9

1 reference

13 December 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

13 December 2017

1 reference

13 December 2017

volume

53

1 reference

13 December 2017

issue

4

1 reference

13 December 2017

page(s)

1148-1153

1 reference

Lamivudine for patients with chronic hepatitis B and advanced liver disease

13 December 2017

cites work

1 reference

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

21 January 2018

1 reference

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

21 January 2018

1 reference

Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response

21 January 2018

1 reference

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

Sequential treatment with lamivudine and alpha-interferon in anti-HBe-positive chronic hepatitis B patients: a pilot study

21 January 2018

1 reference

Antiviral efficacy of adefovir dipivoxil versus lamivudine in patients with chronic hepatitis B sequentially treated with lamivudine and adefovir due to lamivudine resistance

21 January 2018

1 reference

Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.

21 January 2018

1 reference

Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance.

21 January 2018

1 reference

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

21 January 2018

1 reference

Hepatitis B virus infection

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Sequential treatment with lamivudine and interferon-alpha monotherapies in hepatitis B e antigen-negative Chinese patients and its suppression of lamivudine-resistant mutations

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.24192

1 reference

13 December 2017

1 reference